Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
048410.KQ
Top 10 Correlated ETFs
048410.KQ
Top 10 Correlated Stocks
048410.KQ
Financial details
Company Rating
-
Market Cap
717.83B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
64
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-22.69%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
34.18M
Shs Float
31.84M
-
-
-
-
Target Price
-
52W Range
5770.0-22550.0
52W High
-6.87%
52W Low
+263.95%
RSI
27.1
Rel Volume
2.3
Avg Volume
389.92K
Volume
897.12K
Perf Week
-17.16%
Perf Month
-24.05%
Perf Quarter
-
Perf Half Y
-26.06%
-
-
-
-
Beta
1.42947
-
-
Volatility
1060.61%, 6679.15%
Prev Close
-6.46%
Price
21000
Change
-6.25%
Company Profile
- Volume Average 389.92K
- Market Capitalization 717.83B
- Employee 64
- Headquarters Seoul,US
-
Website
https://www.hyundaibioscience.com 
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.
